(Reuters) Tova Cohen and Steven Scheer - Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. Israel is first in the world for the number of medical device patents per capita and second in biopharmaceuticals. Israel has nearly 1,000 life science firms, of which 29% are in biopharma, developing proprietary drugs and experimenting with stem cells to treat diseases such as diabetes, Gaucher and leukemia. Israel has 23 public biotech companies, a total surpassed by only two countries in Europe. There are about 500 medical device firms in Israel that generated more than $1.6 billion in exports in 2011.
2013-06-07 00:00:00Full ArticleBACK Visit the Daily Alert Archive